30 Jan

Arrow declarations: exploiting court flexibility to clear a path to market

Given the difficulty of clearing a path to market for generics and biosimilars, Arrow declarations can serve as a valuable defensive litigation tool in the United Kingdom when patent invalidation or non-infringement judgments are difficult to obtain

Peter Damerell


Powell Gilbert LLP

William Hillson


Powell Gilbert LLP